Wipro Ltd. (NYSE:WIT), a leading global information technology, consulting and outsourcing company, has been named a ‘Leader’ in both R&D ITO & BPO by advisory and research firm International Data Corporation (IDC) in its report IDC MarketScape: Worldwide Life Science Research & Development - BPO 2013 Vendor Assessment, Doc #244934, December 2013 and IDC MarketScape: Worldwide Life Science Research & Development – ITO 2013 Vendor Assessment, Doc #HI245309, December 2013.
After a close evaluation of Wipro's offerings and capabilities, IDC MarketScape has positioned Wipro in the ‘Leaders’ category within R&D ITO and R&D BPO. Relative to other vendors discussed in these reports, and based on feedback from multiple customer references, Wipro received high marks for its strong technical team, solid account relationships, and ability to deliver high value for the money.
Manoj Punja, Senior Vice President and Global Head, Wipro BPO, said, “The Life sciences industry is a huge focus area for Wipro BPO and we are investing significantly in this space. To be named as a Leader by IDC is indeed a validation of our investments and strategy in building differentiated industry capabilities, regulatory knowledge, analytics and best of class operations for this market.’’
Sangita Singh, Senior Vice President and Global Head - Healthcare and Life sciences, Wipro, said, “Wipro has reinforced its position in the R&D space. Wipro Healthcare and life sciences has been pursuing differentiated domain offerings to drive sustainable and predictable growth. We have gained traction, by following Wipro’s three-pronged strategy of programmatic mining of existing accounts, new logo pursuits and creating differentiated domain offerings to solve real problems faced by clients.”Within the Life Science R&D BPO space, Wipro has been quoted as a strong player particularly in the area of delivering enterprise content document management, drug safety services, post market surveillance, and training services. In the Life Science R&D ITO space, Wipro is particularly strong in delivering both industry-specific and industry-agnostic engineering and software ITO services, supplemented by a broad portfolio of traditional life science ITO offerings.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV